Shares of drugmaker Sarepta Therapeutics continued to sink Tuesday after the company said it would comply with a Food and ...

A Massachusetts biotechnology company is laying off 21 employees in Durham amid a broader restructuring and pressure from federal regulators.

A filing with the state details the Columbus job cuts for a biotech cutting more than one-third of its workforce.

The FDA appears to have won its staring contest with Sarepta over shipments of Elevidys, after the company blinked and agreed ...

Sarepta Therapeutics has paused U.S. shipments of its gene therapy Elevidys after two teenagers with Duchenne muscular ...

CMS’s Innovation Center plans to expand its workforce as it prepares to launch new health care payment models.

A local nonprofit is navigating uncertainty with several programs on the chopping block. Disability Rights Ohio serves as an advocate for people with disabilities.

Shares of Sarepta Therapeutics declined 17% in early trading on Friday after another patient who had received an experimental ...

On an investor call Friday, analysts grilled the company over its apparent lack of transparency on the matter.

Sarepta agrees to FDA's black box warning and announces major restructuring, including job cuts and cost-saving measures to ...

The company will pause several gene therapy development programs, for which it intends to seek partners and other strategic alternatives.

A Trump administration proposal could put more than a million low-income households at risk of losing their ...